Form 4: Xylem Inc. Executive Franz Cerwinka Reports Stock Transactions

Franz Cerwinka, SVP & President of AWS & Business Transformation at Xylem Inc., reports acquisition and disposal of company stock and stock options on March 1, 2024.

Summary

• On March 1, 2024, Franz Cerwinka, a Senior Vice President at Xylem Inc., engaged in several transactions involving Xylem's common stock.
• Cerwinka acquired 1,203 shares upon vesting of performance-based restricted stock units related to Total Shareholder Return at a price of $127.94.
• An additional 1,956 shares were acquired upon vesting of performance-based stock units related to ROIC, also at $127.94.
• A total of 1,509 shares were withheld to cover tax liabilities related to the vesting of performance-based stock units.
• Another 730 shares were withheld to cover tax liabilities related to the vesting of restricted stock units granted in 2021, 2022, and 2023.
• Cerwinka was awarded 1,563 restricted stock units that will vest in equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.
• Cerwinka sold 1,341 shares at a weighted average price of $127.44.
• Cerwinka was also granted 5,288 non-qualified stock options that will vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027.
• Following these transactions, Cerwinka directly owns 12,892 shares of Xylem Inc. common stock and 5,288 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document primarily reports routine stock transactions related to executive compensation. The vesting of performance-based units is a positive sign, but the sale of shares introduces a slightly negative element.

Positives

• The vesting of performance-based restricted stock units indicates that the company has met certain performance criteria related to Total Shareholder Return and ROIC.
• The granting of additional restricted stock units and stock options suggests continued confidence in the company's future performance.

Negatives

• The sale of 1,341 shares by Cerwinka could be interpreted negatively by some investors, although it may be for personal financial planning reasons.

Risks

• Tax liabilities from vesting equity awards can lead to selling pressure on the stock.
• Executive stock sales, even for personal reasons, can sometimes be perceived negatively by the market.

Future Outlook

The document indicates future vesting dates for restricted stock units and stock options in 2025, 2026, and 2027, suggesting continued equity-based compensation for the executive.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

• Equity compensation practices, including the use of restricted stock units and stock options, are standard across the industry for companies like Xylem, which operates in the water technology sector.
• Companies such as Danaher, Agilent, and Roper Technologies also utilize similar equity-based compensation plans to incentivize and retain key executives.
• The vesting schedules and performance criteria (TSR and ROIC) are typical metrics used to align executive compensation with shareholder value creation.

Stakeholder Impact

• The vesting of performance-based equity suggests that the company has achieved certain performance targets, which is generally positive for shareholders.
• Executive stock transactions are always of interest to shareholders as they can provide insights into management's view of the company's prospects.

Key Dates